Government Price negotiations on Ozempic and Wegovy

GLP1 Receptor Agonists have certainly reached wide availability for older people first. Medicare and Medicaid have been covering Ozempic and Wegovy for awhile:

Senior citizens and GLP1 Receptor Agonists

GLP1 receptor agonists like Ozempic and Wegovy ease weight loss for senior citizens, but losing weight in old age is a delicate balance.

GLP1 GuideGLP1.Guide Staff

While it isn't easy for most of the rest of the USA to get coverage for GLP1s via insurance, it's particularly easy for those who some might agree most need it. Carrying less weight into old age is almost always a good idea.

Recently the AP reported that the government has started price negotiations for Ozempic and Wegovy:

Ozempic, Wegovy and other drugs are among 15 selected for Medicare’s price negotiations

The Biden administration says popular weight loss drugs like Ozempic and Wegovy have been added to Medicare’s list of medications that will be negotiated directly between the government and drug manufacturers.

AP NewsAMANDA SEITZ

Want to read the rest of our coverage on the various negotiations and implications for medicare/medicaid? The rest of this article is no longer available for free – if you'd like to read the rest of our analysis, check us out on Substack: